Ethnopharmacological relevance: Yiqi Yangxin Anshen Oral Liquid (YQYX) is a multi-herbs compound derived from the ancient Chinese formulae Suanzaoren Decoction and Guipi Tang. It has been clinically using to treat insomnia and anxiety near three decades.Aim of the study: To evaluate the efficacy of YQYX and to elucidate its therapeutic mechanisms in mitigating pathological changes caused by sleep deprivation (SD). Methods: Chemical constituents and serum-absorbed components were characterized by UHPLC-Orbitrap-MS. Network pharmacology predicted therapeutic targets. PCPA-induced SD rats underwent pentobarbital-induced sleep test, Morris water maze, and open field test. Serum inflammatory cytokines were measured by ELISA, hypothalamic neurotransmitters by a validated UHPLC-QQQ-MS/MS method. hippocampal damage was evaluated by H&E and NeuN immunofluorescence, and cAMP/PKA/CREB/BDNF pathway was studied by Western blot. Results: LC-MS identified 102 chemical constituents and 49 serum-absorbed components in YQYX. Network pharmacology analysis based on the serum-absorbed components predicted the cAMP signaling pathway as a key therapeutic target. YQYX significantly ameliorated SD-induced sleeplessness effects, spatial learning-memory impairment, and anxiety-like behaviors. YQYX mitigated inflammation by reducing serum levels of IL-1β, TNF-α, and IL-6. Notably, YQYX restored hypothalamic neurotransmitters homeostasis (serotonin, dopamine, histamine, and acetylcholine). Histological analysis showed that YQYX prevented SD-induced hippocampal damage in CA1 and CA3 regions. Moreall, YQYX could upregulate the cAMP/PKA/CREB/BDNF signaling pathway.Conclusion: YQYX exhibits multi-target therapeutic effects through neurotransmitter homeostasis, anti-neuroinflammation, hippocampal neuroprotection, and neuroplasticity pathway activation, validating its ethnopharmacological basis for treating sleep disorders.
7 February 2023 in Journal of Biochemical and Molecular Toxicology